Cart
sales@molnova.com
PI3K-IN-1
CAS No. 1349796-36-6
PI3K-IN-1( SAR245409 | Voxtalisib )
Catalog No. M11414 CAS No. 1349796-36-6
PI3K-IN-1 is a potent inhibitor of PI3K.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 41 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 111 | In Stock |
|
| 25MG | 219 | In Stock |
|
| 50MG | 305 | In Stock |
|
| 100MG | 494 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1097 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePI3K-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPI3K-IN-1 is a potent inhibitor of PI3K.
-
DescriptionPI3K-IN-1 is a potent inhibitor of PI3K, extracted from patent WO2012103524 A2 and WO2013147649 A2.(In Vitro):PI3K-IN-1 (25 μM) blocks PI3K/Akt signaling pathways. By using the PI3K inhibitor PI3K-IN-1, TGF-β1 induced transformation into myofibroblast is also inhibited, with relatively reduced expressions of α-SMA, Col-1 and Timp-1.
-
In VitroPI3K-IN-1 (25 μM) blocks PI3K/Akt signaling pathways. By using the PI3K inhibitor PI3K-IN-1, TGF-β1 induced transformation into myofibroblast is also inhibited, with relatively reduced expressions of α-SMA, Col-1 and Timp-1.
-
In Vivo——
-
SynonymsSAR245409 | Voxtalisib
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorDNA-PK|PI3Kα|PI3Kβ|PI3Kγ|PI3Kδ
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1349796-36-6
-
Formula Weight599.6569
-
Molecular FormulaC31H29N5O6S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 27.5 mg/mL
-
SMILESO=C(NC1=CC=C(S(=O)(NC2=NC3=CC=CC=C3N=C2NC4=CC(OC)=CC(OC)=C4)=O)C=C1)C5=CC=C(C)C(OC)=C5
-
Chemical NameN-(4-(N-(3-((3,5-dimethoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Palosuran hydrochlor...
Palosuran is a new potent and specific antagonist of the human UT receptor with an IC50 of 3.6±0.2 nM.
-
AMG319
AMG319 (AMG-319) is a potent and selective PI3Kδ inhibitor with biochemical IC50 of 18 nM.
-
Idelalisib (b)
Idelalisib is a selective inhibitor of p110δ(IC50 : 2.5 nM; in cell-free assays); shown to have 40- to 300-fold greater selectivity for p110δ than p110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR.
